Dr Reddys Laboratories (RDY) Long-Term Deferred Tax (2018 - 2026)
Dr Reddys Laboratories (RDY) posted quarterly Long-Term Deferred Tax of $239.0 million for Q1 2026, up 10.14% year-over-year from $217.0 million in Q1 2025, and up 10.14% quarter-over-quarter from $217.0 million in Q1 2025.
Dr Reddys Laboratories (RDY) Long-Term Deferred Tax (2018 - 2026) Analysis & Trends
Dr Reddys Laboratories' Long-Term Deferred Tax history runs 9 years deep, the most recent figure standing at $239.0 million for Q1 2026.
- In Q1 2026, Long-Term Deferred Tax rose 10.14% year-over-year to $239.0 million; the TTM figure through Mar 2026 stood at $239.0 million (up 10.14% YoY), while the FY2026 annual figure was $239.0 million, up 10.14% from the prior year.
- Long-Term Deferred Tax for Q1 2026 stood at $239.0 million, up from $217.0 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $239.0 million in Q1 2026, with the low at $88.0 million in Q1 2023.
- The 5-year median for Long-Term Deferred Tax is $129.0 million (2024), against an average of $156.2 million.
- The sharpest annual moves came in 2022 and 2025: Long-Term Deferred Tax retreated 25.52% in 2022, then surged 68.22% in 2025.
- Dr Reddys Laboratories' Long-Term Deferred Tax stood at $108.0 million in 2022, then slipped by 18.52% to $88.0 million in 2023, then soared by 46.59% to $129.0 million in 2024, then jumped by 68.22% to $217.0 million in 2025, then gained by 10.14% to $239.0 million in 2026.
- Business Quant data shows RDY's Long-Term Deferred Tax at $239.0 million in Q1 2026, $217.0 million in Q1 2025, and $129.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 239.00 Mn |
| Mar 31, 2025 | 217.00 Mn |
| Mar 31, 2024 | 129.00 Mn |
| Mar 31, 2023 | 88.00 Mn |
| Mar 31, 2022 | 108.00 Mn |
| Mar 31, 2021 | 145.00 Mn |
| Mar 31, 2020 | 162.00 Mn |
| Mar 31, 2019 | 60.00 Mn |
| Mar 31, 2018 | 56.00 Mn |